Dividend Powerhouses, often linked to the idea of Dividend Aristocrats, can appeal when growth and inflation signals look mixed and policy paths feel uncertain. A screen that focuses on dividend yields above 5% with coverage, growth and stability aims to spotlight companies that pay investors regularly while keeping those payouts on a solid footing. This does not rely on any single region or sector, which can help when different economies move at different speeds. In this article, you will see three stocks from the Dividend Powerhouses screener that show how this income focused theme can work in practice.
Overview: Canon is a global manufacturer of printers, cameras, medical imaging systems and industrial equipment, supplying everything from office multifunction devices and commercial print systems to CT and x ray scanners, semiconductor tools and security cameras under the Canon brand.
Operations: Canon generates most of its revenue from Printing at ¥2,512.7b, followed by Imaging at ¥1,134.8b, Medical at ¥578.8b and Industrial at ¥346.5b, with smaller contributions from Others and Corporate.
Market Cap: ¥3,867.9b
Canon appears in a high yield screen because it combines a sizable dividend with underlying earnings quality. Net margins are 7.4%, and recent half year results show higher sales and earnings, which supports ongoing payouts. The stock currently trades on a P/E of 10.8x compared with higher averages for regional tech peers, and is indicated as trading at a discount to an estimated fair value. Set against this are some notable issues, including an unstable dividend history, reliance on higher risk borrowing and questions around board independence. For income focused investors, the key question is whether the current discount and earnings profile adequately compensate for these governance and funding risks.
Canon’s low P/E and large dividend hint at a story the market may be underpricing. See how the yield, earnings quality and governance issues line up in the 4 key rewards and 1 important warning sign
Overview: Daiichi Sankyo Company is a global pharmaceutical group that focuses on cancer, cardiovascular and metabolic diseases, neurology, vaccines and specialty care, with flagship oncology drugs such as Enhertu and Datroway alongside a broad range of treatments for conditions like hypertension, diabetes, osteoporosis and migraine.
Operations: Daiichi Sankyo Company generates its ¥2.1t revenue almost entirely from Pharmaceutical Operation, with income spread across Japan, the United States, Europe and other regions.
Market Cap: ¥5.2t
Daiichi Sankyo Company stands out in a high yield screen because it combines a roughly 3.9% dividend with a focus on oncology therapies that are gaining fresh approvals in the US, Europe, China and beyond. Recent guidance for higher revenue and operating profit, plus analyst forecasts for double digit earnings growth, reflect a business that is investing heavily in antibody drug conjugates and already benefiting from products like Enhertu and Datroway. The stock trades below some valuation estimates, yet carries clear trade offs, including heavy reliance on a few blockbuster cancer drugs, higher R&D and a funding base built on external borrowing. For income investors, the key consideration is whether that pipeline and global reach sufficiently offset these concentration and balance sheet risks.
Daiichi Sankyo Company’s oncology engine is accelerating, while its funding and drug concentration risks sit in the background. See how that balance plays out in the 2 key rewards and 2 important warning signs (1 is major!)
Overview: SoftBank is a Japanese telecom and digital services group that runs mobile and broadband networks while also offering cloud, data center, AI, media, e commerce and cashless payment services under brands such as PayPay. Through its Consumer, Enterprise and Financial segments it connects households and businesses and layers on digital tools that sit on top of its communications infrastructure.
Operations: SoftBank generates most of its revenue in Japan, led by Consumer at ¥3,015.1b, Media & EC at ¥1,667.0b and Enterprise at ¥1,002.9b, alongside Distribution at ¥1,056.3b and Financial at ¥404.5b.
Market Cap: ¥11,113.2b
SoftBank combines a telecom style dividend with exposure to AI, data centers and digital payments, which provides income today as well as potential upside if its newer platforms scale. Partnerships with NVIDIA around physical AI and talks with Seven & i and PayPay illustrate how SoftBank could use its network, data and QR payment reach to deepen customer relationships and transaction volumes. At the same time, high debt, intense price competition in Japan’s wireless market and capital heavy AI and 5G projects keep pressure on margins and cash flow. For an income-focused investor, the key consideration is how that mix of yield, AI buildout and funding risk compares when assessing the overall risk and reward profile.
SoftBank’s AI and data center story is accelerating, while its telecom cash flows and debt load pull in the opposite direction. Get the full picture in the analysis report for SoftBank
The three Dividend Powerhouses in this article are only a small sample. The full screen surfaces 460 more companies that combine 3%+ yields with coverage, growth and stable payout records inside the Dividend Powerhouses (3%+ Yield) screener. Use Simply Wall St to identify and analyze the specific catalysts and narratives that matter to you so you can focus on the highest conviction income ideas.
If SoftBank or any of these companies have caught your attention, register for FREE with Simply Wall St and add your companies to a Watchlist to monitor the share price against the fair value and track any new developments as they happen. Once you've made your move, manage your holdings with our Portfolio Command Center that filters out the noise to deliver only the most critical, actionable updates. Throughout your journey, our Community allows you to filter the best ideas from thousands of investor perspectives. By uncovering hidden catalysts and risks early, you'll accelerate your decision-making and stay one step ahead of the market.
Some of the fastest breakout stories start quietly and then move before most investors react. Use these fresh stock lists while the information is still relatively under the radar, and consider them now.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com